Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Van Oortmarssen

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
International Journal of Epidemiology|April 1, 1995
Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smearsG J van Oortmarssen, J D Habbema
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
To screen or not to screen. How do we decide on which cancer screening activities to embark upon?J D Habbema, G J van Oortmarssen
IARC Scientific Publications|January 1, 1986
Cervical cancer screening data from two cohorts in British ColumbiaG J van Oortmarssen, J D Habbema
British Journal of Cancer|September 1, 1991
Epidemiological evidence for age-dependent regression of pre-invasive cervical cancerG J van Oortmarssen, J D Habbema
Bulletin of the World Health Organization|January 1, 1990
The predicted and observed decline in onchocerciasis infection during 14 years of successful control of Simulium spp. in west AfricaJ Remme, G De Sole, G J van Oortmarssen
Statistical Methods in Medical Research|March 1, 1995
Modelling issues in cancer screeningG J van Oortmarssen, R Boer, J D Habbema
Leprosy Review|September 1, 1992
Towards the use of decision sciences in leprosy controlJ D Habbema, E Jozefzoon, G J Van Oortmarssen
JAMA|January 10, 1996
Cost-effectiveness of mammography screeningR Boer, G J van Oortmarssen, H J de Koning
BMJ (Clinical Research Ed.)|August 22, 1992
Predicting mortality from cervical cancer after negative smear test resultsG J van Oortmarssen, J D Habbema, M van Ballegooijen
Transactions of the Royal Society of Tropical Medicine and Hygiene|November 1, 1992
Validation of a model for variations in Schistosoma mansoni egg countsS J de Vlas, G J van Oortmarssen, B Gryseels
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
International Journal of Epidemiology|April 1, 1995
Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smearsG J van Oortmarssen, J D Habbema
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
To screen or not to screen. How do we decide on which cancer screening activities to embark upon?J D Habbema, G J van Oortmarssen
IARC Scientific Publications|January 1, 1986
Cervical cancer screening data from two cohorts in British ColumbiaG J van Oortmarssen, J D Habbema
British Journal of Cancer|September 1, 1991
Epidemiological evidence for age-dependent regression of pre-invasive cervical cancerG J van Oortmarssen, J D Habbema
Bulletin of the World Health Organization|January 1, 1990
The predicted and observed decline in onchocerciasis infection during 14 years of successful control of Simulium spp. in west AfricaJ Remme, G De Sole, G J van Oortmarssen
Statistical Methods in Medical Research|March 1, 1995
Modelling issues in cancer screeningG J van Oortmarssen, R Boer, J D Habbema
Leprosy Review|September 1, 1992
Towards the use of decision sciences in leprosy controlJ D Habbema, E Jozefzoon, G J Van Oortmarssen
JAMA|January 10, 1996
Cost-effectiveness of mammography screeningR Boer, G J van Oortmarssen, H J de Koning
BMJ (Clinical Research Ed.)|August 22, 1992
Predicting mortality from cervical cancer after negative smear test resultsG J van Oortmarssen, J D Habbema, M van Ballegooijen
Transactions of the Royal Society of Tropical Medicine and Hygiene|November 1, 1992
Validation of a model for variations in Schistosoma mansoni egg countsS J de Vlas, G J van Oortmarssen, B Gryseels
Pageof 8